Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Celestica (NY:CLS)

70.11 -12.23 (-14.86%)
Streaming Delayed Price Updated: 2:37 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Celestica

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Celestica Files Form 20-F
From Celestica International LP
Via GlobeNewswire
Celestica Announces 2023 Annual Meeting of Shareholders
From Celestica International LP
Via GlobeNewswire
Celestica Announces Fourth Quarter 2022 Financial Results
Performance exceeds the high end of 4th quarter guidance; reaffirms outlook for 2023 
From Celestica International LP
Via GlobeNewswire
Contract Manufacturer Flex Bends On Lowered Earnings Outlook
Electronics contract manufacturer Flex topped estimates for its fiscal third quarter. But its guidance disappointed. Flex stock fell. 
Via Investor's Business Daily
Celestica's Earnings: A Preview
Via Benzinga
Earnings Scheduled For January 25, 2023
Companies Reporting Before The Bell • ASML Holding (NASDAQ:ASML) is expected to report quarterly earnings at $4.45 per share on revenue of $6.50 billion. 
Via Benzinga
Celestica Q4 2022 Financial Results and Conference Call Thursday, January 26, 2023
From Celestica International LP
Via GlobeNewswire
Celestica Announces TSX Acceptance of Normal Course Issuer Bid
From Celestica International LP
Via GlobeNewswire
Jill Kale Appointed to Celestica’s Board of Directors
From Celestica International LP
Via GlobeNewswire
Stock-ing Stuffers: 3 Attractive Stocks Trading Around $10
These three stocks have been dragged down by the tide but, with cheap valuations and long-term growth stories intact, are positioned for a happier new year. 
Via MarketBeat
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company. 
Via Benzinga
Aaron's, Celestica, Medpace Holdings And Some Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Crown Holdings Shares Are Trading Lower By Around 22%? Here Are 46 Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Celestica Announces Third Quarter 2022 Financial Results
(All amounts in U.S. dollars. Per share information based on diluted shares outstanding unless otherwise noted.) 
From Celestica International LP
Via GlobeNewswire
Earnings Scheduled For October 24, 2022
Companies Reporting Before The Bell • Imperial Ptrl (NASDAQ:IMPP) is likely to report earnings for its third quarter. 
Via Benzinga
Earnings Outlook For Celestica
Celestica (NYSE:CLS) is set to give its latest quarterly earnings report on Monday, 2022-10-24. Here's what investors need to know before the announcement. Analysts estimate that Celestica will report... 
Via Benzinga
Celestica’s New Ethernet Switch Will Help Propel Open Networking
Celestica contributes the complete design specification and all design files for the new DS1000 Ethernet switch at 2022 OCP Global Summit 
From Celestica International LP
Via GlobeNewswire
Françoise Colpron Appointed to Celestica’s Board of Directors
From Celestica International LP
Via GlobeNewswire
Celestica Q3 2022 Financial Results and Conference Call Tuesday, October 25, 2022
From Celestica International LP
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2022
  
Via Benzinga
7 Small-Cap Growth Stocks With Multibagger Potential
These multibagger small-cap growth stocks have rock-solid underlying businesses that can gain significant traction down the road. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2022
  
Via Benzinga
Celestica's Earnings: A Preview
Celestica (NYSE:CLS) is set to give its latest quarterly earnings report on Monday, 2022-07-25. Here's what investors need to know before the announcement. Analysts estimate that Celestica will report... 
Via Benzinga
Jabil Stock Near Buy Zone With Quarterly Earnings Due
With earnings on tap for Jun. 17, IBD 50 member Jabil stock is currently about 15% under a 72.21 buy point. 
Via Investor's Business Daily
7 Small-Cap Stocks to Buy for Massive Gains in the Next 10 Years
These small-cap stocks to buy have immense long-term potential for healthy gains and make a splash in the coming decade. 
Via InvestorPlace
Earnings Scheduled For July 25, 2022
Companies Reporting Before The Bell • Lakeland Financial (NASDAQ:LKFN) is estimated to report quarterly earnings at $0.95 per share on revenue of $59.26 million. 
Via Benzinga
Jabil Builds Chips, Autos And Passes Huge Milestone
Jabil shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 74 to 85. 
Via Investor's Business Daily
Earnings Outlook For Celestica
Celestica (NYSE:CLS) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Celestica will... 
Via Benzinga
3 Undervalued Small-Cap Stocks to Buy Now
Here are three undervalued stocks to consider buying now as the shift to valuation becomes the dominant theme in 2022. 
Via InvestorPlace
Urbx Logistics Selects Celestica to Manufacture its Automated eCommerce System
Urbx Leverages Celestica's Robotics Center of Excellence To Meet Rising Demand Among Retailers for Faster, More Efficient, Cost-Effective Order Fulfillment and Delivery Systems BOSTON, MA / ACCESSWIRE... 
From Urbx
Via AccessWire
Topics Economy
Exposures Supply Chain
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.